SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-22-011109
Filing Date
2022-04-28
Accepted
2022-04-28 16:11:02
Documents
9
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A ocgn-20220428xdef14a.htm DEF 14A 718826
2 GRAPHIC ceosignature.jpg GRAPHIC 14639
3 GRAPHIC chart-6c1da7e5cf8947b1be4a.jpg GRAPHIC 36422
4 GRAPHIC chart-b222529e641b446391da.jpg GRAPHIC 33387
5 GRAPHIC checkmark.jpg GRAPHIC 9077
6 GRAPHIC ocgnlogoa.jpg GRAPHIC 27940
7 GRAPHIC proxycardpage1a.jpg GRAPHIC 606931
8 GRAPHIC proxycardpage2a.jpg GRAPHIC 380085
9 GRAPHIC votingmethodsa.jpg GRAPHIC 35641
  Complete submission text file 0001628280-22-011109.txt   2294609
Mailing Address 263 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 263 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36751 | Film No.: 22866632
SIC: 2836 Biological Products, (No Diagnostic Substances)